nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—CYP2B6—Thiotepa—urinary bladder cancer	0.107	0.17	CbGbCtD
Venlafaxine—ABCB1—Mitomycin—urinary bladder cancer	0.0723	0.115	CbGbCtD
Venlafaxine—ABCG2—Fluorouracil—urinary bladder cancer	0.0494	0.0787	CbGbCtD
Venlafaxine—ABCG2—Carboplatin—urinary bladder cancer	0.0491	0.0782	CbGbCtD
Venlafaxine—ABCG2—Cisplatin—urinary bladder cancer	0.0419	0.0668	CbGbCtD
Venlafaxine—ABCG2—Etoposide—urinary bladder cancer	0.0412	0.0657	CbGbCtD
Venlafaxine—CYP3A4—Thiotepa—urinary bladder cancer	0.0328	0.0523	CbGbCtD
Venlafaxine—CYP2B6—Cisplatin—urinary bladder cancer	0.0295	0.047	CbGbCtD
Venlafaxine—ABCG2—Doxorubicin—urinary bladder cancer	0.0281	0.0448	CbGbCtD
Venlafaxine—ABCG2—Methotrexate—urinary bladder cancer	0.0272	0.0434	CbGbCtD
Venlafaxine—ABCB1—Gemcitabine—urinary bladder cancer	0.0208	0.0332	CbGbCtD
Venlafaxine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0198	0.0315	CbGbCtD
Venlafaxine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0183	0.0292	CbGbCtD
Venlafaxine—CYP2C9—Cisplatin—urinary bladder cancer	0.0156	0.0248	CbGbCtD
Venlafaxine—ABCB1—Cisplatin—urinary bladder cancer	0.0151	0.0241	CbGbCtD
Venlafaxine—ABCB1—Etoposide—urinary bladder cancer	0.0149	0.0237	CbGbCtD
Venlafaxine—ABCB1—Doxorubicin—urinary bladder cancer	0.0101	0.0162	CbGbCtD
Venlafaxine—ABCB1—Methotrexate—urinary bladder cancer	0.00981	0.0156	CbGbCtD
Venlafaxine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00955	0.0152	CbGbCtD
Venlafaxine—CYP3A4—Etoposide—urinary bladder cancer	0.0089	0.0142	CbGbCtD
Venlafaxine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00607	0.00968	CbGbCtD
Venlafaxine—NPY1R—prostate gland—urinary bladder cancer	0.00467	0.102	CbGeAlD
Venlafaxine—CYP2C19—urine—urinary bladder cancer	0.00416	0.0908	CbGeAlD
Venlafaxine—NPY1R—seminal vesicle—urinary bladder cancer	0.00395	0.0862	CbGeAlD
Venlafaxine—CYP2C9—urine—urinary bladder cancer	0.00322	0.0704	CbGeAlD
Venlafaxine—NPY1R—renal system—urinary bladder cancer	0.00318	0.0695	CbGeAlD
Venlafaxine—NPY1R—female reproductive system—urinary bladder cancer	0.00255	0.0557	CbGeAlD
Venlafaxine—CYP3A4—urine—urinary bladder cancer	0.00246	0.0537	CbGeAlD
Venlafaxine—CYP2D6—urine—urinary bladder cancer	0.00242	0.0528	CbGeAlD
Venlafaxine—NPY1R—vagina—urinary bladder cancer	0.00231	0.0503	CbGeAlD
Venlafaxine—NPY1R—lymph node—urinary bladder cancer	0.00149	0.0326	CbGeAlD
Venlafaxine—ABCG2—prostate gland—urinary bladder cancer	0.00127	0.0276	CbGeAlD
Venlafaxine—ABCG2—seminal vesicle—urinary bladder cancer	0.00107	0.0234	CbGeAlD
Venlafaxine—SLC6A4—female reproductive system—urinary bladder cancer	0.000983	0.0215	CbGeAlD
Venlafaxine—SLC6A2—female reproductive system—urinary bladder cancer	0.000866	0.0189	CbGeAlD
Venlafaxine—ABCG2—urethra—urinary bladder cancer	0.000848	0.0185	CbGeAlD
Venlafaxine—CYP2B6—renal system—urinary bladder cancer	0.000796	0.0174	CbGeAlD
Venlafaxine—CYP2C19—vagina—urinary bladder cancer	0.000737	0.0161	CbGeAlD
Venlafaxine—CYP2B6—female reproductive system—urinary bladder cancer	0.000638	0.0139	CbGeAlD
Venlafaxine—CYP2C9—female reproductive system—urinary bladder cancer	0.000632	0.0138	CbGeAlD
Venlafaxine—ABCG2—vagina—urinary bladder cancer	0.000625	0.0136	CbGeAlD
Venlafaxine—ABCB1—prostate gland—urinary bladder cancer	0.000625	0.0136	CbGeAlD
Venlafaxine—CYP3A4—renal system—urinary bladder cancer	0.000601	0.0131	CbGeAlD
Venlafaxine—CYP2D6—renal system—urinary bladder cancer	0.000592	0.0129	CbGeAlD
Venlafaxine—CYP2B6—vagina—urinary bladder cancer	0.000577	0.0126	CbGeAlD
Venlafaxine—ABCB1—seminal vesicle—urinary bladder cancer	0.000528	0.0115	CbGeAlD
Venlafaxine—SLC6A2—lymph node—urinary bladder cancer	0.000506	0.0111	CbGeAlD
Venlafaxine—CYP3A4—female reproductive system—urinary bladder cancer	0.000482	0.0105	CbGeAlD
Venlafaxine—CYP2D6—female reproductive system—urinary bladder cancer	0.000474	0.0103	CbGeAlD
Venlafaxine—ABCB1—epithelium—urinary bladder cancer	0.000459	0.01	CbGeAlD
Venlafaxine—ABCB1—renal system—urinary bladder cancer	0.000426	0.00929	CbGeAlD
Venlafaxine—ABCB1—urethra—urinary bladder cancer	0.000418	0.00913	CbGeAlD
Venlafaxine—ABCG2—lymph node—urinary bladder cancer	0.000404	0.00883	CbGeAlD
Venlafaxine—ABCB1—female reproductive system—urinary bladder cancer	0.000341	0.00744	CbGeAlD
Venlafaxine—ABCB1—vagina—urinary bladder cancer	0.000308	0.00673	CbGeAlD
Venlafaxine—ABCB1—lymph node—urinary bladder cancer	0.000199	0.00435	CbGeAlD
Venlafaxine—Gastrointestinal pain—Etoposide—urinary bladder cancer	8.75e-05	0.00034	CcSEcCtD
Venlafaxine—Pruritus—Fluorouracil—urinary bladder cancer	8.72e-05	0.000339	CcSEcCtD
Venlafaxine—Visual impairment—Methotrexate—urinary bladder cancer	8.7e-05	0.000338	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	8.63e-05	0.000335	CcSEcCtD
Venlafaxine—Hypersensitivity—Cisplatin—urinary bladder cancer	8.61e-05	0.000334	CcSEcCtD
Venlafaxine—Bradycardia—Epirubicin—urinary bladder cancer	8.6e-05	0.000334	CcSEcCtD
Venlafaxine—Diarrhoea—Gemcitabine—urinary bladder cancer	8.58e-05	0.000333	CcSEcCtD
Venlafaxine—Renal failure—Doxorubicin—urinary bladder cancer	8.56e-05	0.000332	CcSEcCtD
Venlafaxine—Erythema multiforme—Methotrexate—urinary bladder cancer	8.53e-05	0.000331	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	8.53e-05	0.000331	CcSEcCtD
Venlafaxine—Urticaria—Etoposide—urinary bladder cancer	8.5e-05	0.00033	CcSEcCtD
Venlafaxine—Haemoglobin—Epirubicin—urinary bladder cancer	8.49e-05	0.00033	CcSEcCtD
Venlafaxine—Jaundice—Doxorubicin—urinary bladder cancer	8.48e-05	0.000329	CcSEcCtD
Venlafaxine—Stomatitis—Doxorubicin—urinary bladder cancer	8.48e-05	0.000329	CcSEcCtD
Venlafaxine—Rhinitis—Epirubicin—urinary bladder cancer	8.47e-05	0.000329	CcSEcCtD
Venlafaxine—Abdominal pain—Etoposide—urinary bladder cancer	8.46e-05	0.000329	CcSEcCtD
Venlafaxine—Body temperature increased—Etoposide—urinary bladder cancer	8.46e-05	0.000329	CcSEcCtD
Venlafaxine—Conjunctivitis—Doxorubicin—urinary bladder cancer	8.46e-05	0.000329	CcSEcCtD
Venlafaxine—Haemorrhage—Epirubicin—urinary bladder cancer	8.44e-05	0.000328	CcSEcCtD
Venlafaxine—Hepatitis—Epirubicin—urinary bladder cancer	8.44e-05	0.000328	CcSEcCtD
Venlafaxine—Diarrhoea—Fluorouracil—urinary bladder cancer	8.43e-05	0.000327	CcSEcCtD
Venlafaxine—Tinnitus—Methotrexate—urinary bladder cancer	8.41e-05	0.000327	CcSEcCtD
Venlafaxine—Hypoaesthesia—Epirubicin—urinary bladder cancer	8.4e-05	0.000326	CcSEcCtD
Venlafaxine—Asthenia—Cisplatin—urinary bladder cancer	8.38e-05	0.000325	CcSEcCtD
Venlafaxine—Pharyngitis—Epirubicin—urinary bladder cancer	8.38e-05	0.000325	CcSEcCtD
Venlafaxine—Cardiac disorder—Methotrexate—urinary bladder cancer	8.37e-05	0.000325	CcSEcCtD
Venlafaxine—Sweating—Doxorubicin—urinary bladder cancer	8.34e-05	0.000324	CcSEcCtD
Venlafaxine—Haematuria—Doxorubicin—urinary bladder cancer	8.3e-05	0.000322	CcSEcCtD
Venlafaxine—Epistaxis—Doxorubicin—urinary bladder cancer	8.21e-05	0.000319	CcSEcCtD
Venlafaxine—Sinusitis—Doxorubicin—urinary bladder cancer	8.17e-05	0.000317	CcSEcCtD
Venlafaxine—Dizziness—Fluorouracil—urinary bladder cancer	8.15e-05	0.000316	CcSEcCtD
Venlafaxine—Visual impairment—Epirubicin—urinary bladder cancer	8.14e-05	0.000316	CcSEcCtD
Venlafaxine—Agranulocytosis—Doxorubicin—urinary bladder cancer	8.12e-05	0.000315	CcSEcCtD
Venlafaxine—Chills—Methotrexate—urinary bladder cancer	8.1e-05	0.000314	CcSEcCtD
Venlafaxine—Diarrhoea—Cisplatin—urinary bladder cancer	7.99e-05	0.00031	CcSEcCtD
Venlafaxine—Erythema multiforme—Epirubicin—urinary bladder cancer	7.98e-05	0.00031	CcSEcCtD
Venlafaxine—Alopecia—Methotrexate—urinary bladder cancer	7.97e-05	0.00031	CcSEcCtD
Venlafaxine—Vomiting—Gemcitabine—urinary bladder cancer	7.97e-05	0.000309	CcSEcCtD
Venlafaxine—Bradycardia—Doxorubicin—urinary bladder cancer	7.95e-05	0.000309	CcSEcCtD
Venlafaxine—Rash—Gemcitabine—urinary bladder cancer	7.9e-05	0.000307	CcSEcCtD
Venlafaxine—Dermatitis—Gemcitabine—urinary bladder cancer	7.9e-05	0.000307	CcSEcCtD
Venlafaxine—Hypersensitivity—Etoposide—urinary bladder cancer	7.89e-05	0.000306	CcSEcCtD
Venlafaxine—Tinnitus—Epirubicin—urinary bladder cancer	7.87e-05	0.000306	CcSEcCtD
Venlafaxine—Erythema—Methotrexate—urinary bladder cancer	7.85e-05	0.000305	CcSEcCtD
Venlafaxine—Haemoglobin—Doxorubicin—urinary bladder cancer	7.85e-05	0.000305	CcSEcCtD
Venlafaxine—Headache—Gemcitabine—urinary bladder cancer	7.85e-05	0.000305	CcSEcCtD
Venlafaxine—Cardiac disorder—Epirubicin—urinary bladder cancer	7.84e-05	0.000304	CcSEcCtD
Venlafaxine—Flushing—Epirubicin—urinary bladder cancer	7.84e-05	0.000304	CcSEcCtD
Venlafaxine—Vomiting—Fluorouracil—urinary bladder cancer	7.84e-05	0.000304	CcSEcCtD
Venlafaxine—Rhinitis—Doxorubicin—urinary bladder cancer	7.83e-05	0.000304	CcSEcCtD
Venlafaxine—Haemorrhage—Doxorubicin—urinary bladder cancer	7.81e-05	0.000303	CcSEcCtD
Venlafaxine—Hepatitis—Doxorubicin—urinary bladder cancer	7.81e-05	0.000303	CcSEcCtD
Venlafaxine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	7.77e-05	0.000302	CcSEcCtD
Venlafaxine—Rash—Fluorouracil—urinary bladder cancer	7.77e-05	0.000302	CcSEcCtD
Venlafaxine—Dermatitis—Fluorouracil—urinary bladder cancer	7.76e-05	0.000301	CcSEcCtD
Venlafaxine—Pharyngitis—Doxorubicin—urinary bladder cancer	7.75e-05	0.000301	CcSEcCtD
Venlafaxine—Headache—Fluorouracil—urinary bladder cancer	7.72e-05	0.0003	CcSEcCtD
Venlafaxine—Dysgeusia—Methotrexate—urinary bladder cancer	7.69e-05	0.000299	CcSEcCtD
Venlafaxine—Asthenia—Etoposide—urinary bladder cancer	7.68e-05	0.000298	CcSEcCtD
Venlafaxine—Back pain—Methotrexate—urinary bladder cancer	7.6e-05	0.000295	CcSEcCtD
Venlafaxine—Chills—Epirubicin—urinary bladder cancer	7.58e-05	0.000294	CcSEcCtD
Venlafaxine—Pruritus—Etoposide—urinary bladder cancer	7.57e-05	0.000294	CcSEcCtD
Venlafaxine—Arrhythmia—Epirubicin—urinary bladder cancer	7.54e-05	0.000293	CcSEcCtD
Venlafaxine—Visual impairment—Doxorubicin—urinary bladder cancer	7.53e-05	0.000292	CcSEcCtD
Venlafaxine—Alopecia—Epirubicin—urinary bladder cancer	7.46e-05	0.00029	CcSEcCtD
Venlafaxine—Nausea—Gemcitabine—urinary bladder cancer	7.44e-05	0.000289	CcSEcCtD
Venlafaxine—Vomiting—Cisplatin—urinary bladder cancer	7.43e-05	0.000288	CcSEcCtD
Venlafaxine—Vision blurred—Methotrexate—urinary bladder cancer	7.4e-05	0.000287	CcSEcCtD
Venlafaxine—Erythema multiforme—Doxorubicin—urinary bladder cancer	7.39e-05	0.000287	CcSEcCtD
Venlafaxine—Rash—Cisplatin—urinary bladder cancer	7.37e-05	0.000286	CcSEcCtD
Venlafaxine—Dermatitis—Cisplatin—urinary bladder cancer	7.36e-05	0.000286	CcSEcCtD
Venlafaxine—Erythema—Epirubicin—urinary bladder cancer	7.35e-05	0.000285	CcSEcCtD
Venlafaxine—Diarrhoea—Etoposide—urinary bladder cancer	7.32e-05	0.000284	CcSEcCtD
Venlafaxine—Nausea—Fluorouracil—urinary bladder cancer	7.32e-05	0.000284	CcSEcCtD
Venlafaxine—Ill-defined disorder—Methotrexate—urinary bladder cancer	7.29e-05	0.000283	CcSEcCtD
Venlafaxine—Tinnitus—Doxorubicin—urinary bladder cancer	7.28e-05	0.000283	CcSEcCtD
Venlafaxine—Anaemia—Methotrexate—urinary bladder cancer	7.26e-05	0.000282	CcSEcCtD
Venlafaxine—Flushing—Doxorubicin—urinary bladder cancer	7.25e-05	0.000282	CcSEcCtD
Venlafaxine—Cardiac disorder—Doxorubicin—urinary bladder cancer	7.25e-05	0.000282	CcSEcCtD
Venlafaxine—Flatulence—Epirubicin—urinary bladder cancer	7.24e-05	0.000281	CcSEcCtD
Venlafaxine—Tension—Epirubicin—urinary bladder cancer	7.21e-05	0.00028	CcSEcCtD
Venlafaxine—Dysgeusia—Epirubicin—urinary bladder cancer	7.2e-05	0.00028	CcSEcCtD
Venlafaxine—Nervousness—Epirubicin—urinary bladder cancer	7.14e-05	0.000277	CcSEcCtD
Venlafaxine—Back pain—Epirubicin—urinary bladder cancer	7.11e-05	0.000276	CcSEcCtD
Venlafaxine—Malaise—Methotrexate—urinary bladder cancer	7.08e-05	0.000275	CcSEcCtD
Venlafaxine—Dizziness—Etoposide—urinary bladder cancer	7.08e-05	0.000275	CcSEcCtD
Venlafaxine—Muscle spasms—Epirubicin—urinary bladder cancer	7.07e-05	0.000274	CcSEcCtD
Venlafaxine—Vertigo—Methotrexate—urinary bladder cancer	7.06e-05	0.000274	CcSEcCtD
Venlafaxine—Leukopenia—Methotrexate—urinary bladder cancer	7.03e-05	0.000273	CcSEcCtD
Venlafaxine—Chills—Doxorubicin—urinary bladder cancer	7.01e-05	0.000272	CcSEcCtD
Venlafaxine—Arrhythmia—Doxorubicin—urinary bladder cancer	6.98e-05	0.000271	CcSEcCtD
Venlafaxine—Nausea—Cisplatin—urinary bladder cancer	6.94e-05	0.000269	CcSEcCtD
Venlafaxine—Vision blurred—Epirubicin—urinary bladder cancer	6.93e-05	0.000269	CcSEcCtD
Venlafaxine—Alopecia—Doxorubicin—urinary bladder cancer	6.9e-05	0.000268	CcSEcCtD
Venlafaxine—Cough—Methotrexate—urinary bladder cancer	6.85e-05	0.000266	CcSEcCtD
Venlafaxine—Ill-defined disorder—Epirubicin—urinary bladder cancer	6.82e-05	0.000265	CcSEcCtD
Venlafaxine—Convulsion—Methotrexate—urinary bladder cancer	6.81e-05	0.000264	CcSEcCtD
Venlafaxine—Vomiting—Etoposide—urinary bladder cancer	6.8e-05	0.000264	CcSEcCtD
Venlafaxine—Erythema—Doxorubicin—urinary bladder cancer	6.8e-05	0.000264	CcSEcCtD
Venlafaxine—Anaemia—Epirubicin—urinary bladder cancer	6.79e-05	0.000264	CcSEcCtD
Venlafaxine—Agitation—Epirubicin—urinary bladder cancer	6.76e-05	0.000262	CcSEcCtD
Venlafaxine—Rash—Etoposide—urinary bladder cancer	6.75e-05	0.000262	CcSEcCtD
Venlafaxine—Dermatitis—Etoposide—urinary bladder cancer	6.74e-05	0.000262	CcSEcCtD
Venlafaxine—Headache—Etoposide—urinary bladder cancer	6.7e-05	0.00026	CcSEcCtD
Venlafaxine—Flatulence—Doxorubicin—urinary bladder cancer	6.7e-05	0.00026	CcSEcCtD
Venlafaxine—Arthralgia—Methotrexate—urinary bladder cancer	6.69e-05	0.00026	CcSEcCtD
Venlafaxine—Myalgia—Methotrexate—urinary bladder cancer	6.69e-05	0.00026	CcSEcCtD
Venlafaxine—Chest pain—Methotrexate—urinary bladder cancer	6.69e-05	0.00026	CcSEcCtD
Venlafaxine—Tension—Doxorubicin—urinary bladder cancer	6.67e-05	0.000259	CcSEcCtD
Venlafaxine—Dysgeusia—Doxorubicin—urinary bladder cancer	6.66e-05	0.000259	CcSEcCtD
Venlafaxine—Malaise—Epirubicin—urinary bladder cancer	6.63e-05	0.000257	CcSEcCtD
Venlafaxine—Discomfort—Methotrexate—urinary bladder cancer	6.61e-05	0.000257	CcSEcCtD
Venlafaxine—Nervousness—Doxorubicin—urinary bladder cancer	6.61e-05	0.000257	CcSEcCtD
Venlafaxine—Vertigo—Epirubicin—urinary bladder cancer	6.6e-05	0.000256	CcSEcCtD
Venlafaxine—Syncope—Epirubicin—urinary bladder cancer	6.59e-05	0.000256	CcSEcCtD
Venlafaxine—Leukopenia—Epirubicin—urinary bladder cancer	6.58e-05	0.000256	CcSEcCtD
Venlafaxine—Back pain—Doxorubicin—urinary bladder cancer	6.58e-05	0.000255	CcSEcCtD
Venlafaxine—Muscle spasms—Doxorubicin—urinary bladder cancer	6.54e-05	0.000254	CcSEcCtD
Venlafaxine—Palpitations—Epirubicin—urinary bladder cancer	6.5e-05	0.000252	CcSEcCtD
Venlafaxine—Confusional state—Methotrexate—urinary bladder cancer	6.46e-05	0.000251	CcSEcCtD
Venlafaxine—Loss of consciousness—Epirubicin—urinary bladder cancer	6.46e-05	0.000251	CcSEcCtD
Venlafaxine—Cough—Epirubicin—urinary bladder cancer	6.41e-05	0.000249	CcSEcCtD
Venlafaxine—Anaphylactic shock—Methotrexate—urinary bladder cancer	6.41e-05	0.000249	CcSEcCtD
Venlafaxine—Vision blurred—Doxorubicin—urinary bladder cancer	6.41e-05	0.000249	CcSEcCtD
Venlafaxine—Convulsion—Epirubicin—urinary bladder cancer	6.37e-05	0.000247	CcSEcCtD
Venlafaxine—Infection—Methotrexate—urinary bladder cancer	6.37e-05	0.000247	CcSEcCtD
Venlafaxine—Nausea—Etoposide—urinary bladder cancer	6.36e-05	0.000247	CcSEcCtD
Venlafaxine—Hypertension—Epirubicin—urinary bladder cancer	6.35e-05	0.000246	CcSEcCtD
Venlafaxine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	6.31e-05	0.000245	CcSEcCtD
Venlafaxine—Anaemia—Doxorubicin—urinary bladder cancer	6.29e-05	0.000244	CcSEcCtD
Venlafaxine—Thrombocytopenia—Methotrexate—urinary bladder cancer	6.28e-05	0.000244	CcSEcCtD
Venlafaxine—Arthralgia—Epirubicin—urinary bladder cancer	6.26e-05	0.000243	CcSEcCtD
Venlafaxine—Chest pain—Epirubicin—urinary bladder cancer	6.26e-05	0.000243	CcSEcCtD
Venlafaxine—Myalgia—Epirubicin—urinary bladder cancer	6.26e-05	0.000243	CcSEcCtD
Venlafaxine—Agitation—Doxorubicin—urinary bladder cancer	6.25e-05	0.000243	CcSEcCtD
Venlafaxine—Anxiety—Epirubicin—urinary bladder cancer	6.24e-05	0.000242	CcSEcCtD
Venlafaxine—Hyperhidrosis—Methotrexate—urinary bladder cancer	6.2e-05	0.000241	CcSEcCtD
Venlafaxine—Discomfort—Epirubicin—urinary bladder cancer	6.18e-05	0.00024	CcSEcCtD
Venlafaxine—Malaise—Doxorubicin—urinary bladder cancer	6.13e-05	0.000238	CcSEcCtD
Venlafaxine—Dry mouth—Epirubicin—urinary bladder cancer	6.12e-05	0.000238	CcSEcCtD
Venlafaxine—Vertigo—Doxorubicin—urinary bladder cancer	6.11e-05	0.000237	CcSEcCtD
Venlafaxine—Anorexia—Methotrexate—urinary bladder cancer	6.11e-05	0.000237	CcSEcCtD
Venlafaxine—Syncope—Doxorubicin—urinary bladder cancer	6.1e-05	0.000237	CcSEcCtD
Venlafaxine—Leukopenia—Doxorubicin—urinary bladder cancer	6.09e-05	0.000236	CcSEcCtD
Venlafaxine—Confusional state—Epirubicin—urinary bladder cancer	6.05e-05	0.000235	CcSEcCtD
Venlafaxine—Palpitations—Doxorubicin—urinary bladder cancer	6.01e-05	0.000233	CcSEcCtD
Venlafaxine—Anaphylactic shock—Epirubicin—urinary bladder cancer	6e-05	0.000233	CcSEcCtD
Venlafaxine—Oedema—Epirubicin—urinary bladder cancer	6e-05	0.000233	CcSEcCtD
Venlafaxine—Hypotension—Methotrexate—urinary bladder cancer	5.99e-05	0.000233	CcSEcCtD
Venlafaxine—Loss of consciousness—Doxorubicin—urinary bladder cancer	5.98e-05	0.000232	CcSEcCtD
Venlafaxine—Infection—Epirubicin—urinary bladder cancer	5.96e-05	0.000231	CcSEcCtD
Venlafaxine—Cough—Doxorubicin—urinary bladder cancer	5.94e-05	0.00023	CcSEcCtD
Venlafaxine—Shock—Epirubicin—urinary bladder cancer	5.9e-05	0.000229	CcSEcCtD
Venlafaxine—Convulsion—Doxorubicin—urinary bladder cancer	5.89e-05	0.000229	CcSEcCtD
Venlafaxine—Thrombocytopenia—Epirubicin—urinary bladder cancer	5.87e-05	0.000228	CcSEcCtD
Venlafaxine—Hypertension—Doxorubicin—urinary bladder cancer	5.87e-05	0.000228	CcSEcCtD
Venlafaxine—Tachycardia—Epirubicin—urinary bladder cancer	5.86e-05	0.000227	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	5.84e-05	0.000227	CcSEcCtD
Venlafaxine—Hyperhidrosis—Epirubicin—urinary bladder cancer	5.8e-05	0.000225	CcSEcCtD
Venlafaxine—Insomnia—Methotrexate—urinary bladder cancer	5.8e-05	0.000225	CcSEcCtD
Venlafaxine—Arthralgia—Doxorubicin—urinary bladder cancer	5.79e-05	0.000225	CcSEcCtD
Venlafaxine—Myalgia—Doxorubicin—urinary bladder cancer	5.79e-05	0.000225	CcSEcCtD
Venlafaxine—Chest pain—Doxorubicin—urinary bladder cancer	5.79e-05	0.000225	CcSEcCtD
Venlafaxine—Anxiety—Doxorubicin—urinary bladder cancer	5.77e-05	0.000224	CcSEcCtD
Venlafaxine—Paraesthesia—Methotrexate—urinary bladder cancer	5.76e-05	0.000224	CcSEcCtD
Venlafaxine—Discomfort—Doxorubicin—urinary bladder cancer	5.72e-05	0.000222	CcSEcCtD
Venlafaxine—Anorexia—Epirubicin—urinary bladder cancer	5.72e-05	0.000222	CcSEcCtD
Venlafaxine—Dyspnoea—Methotrexate—urinary bladder cancer	5.72e-05	0.000222	CcSEcCtD
Venlafaxine—Somnolence—Methotrexate—urinary bladder cancer	5.7e-05	0.000221	CcSEcCtD
Venlafaxine—Dry mouth—Doxorubicin—urinary bladder cancer	5.66e-05	0.00022	CcSEcCtD
Venlafaxine—Dyspepsia—Methotrexate—urinary bladder cancer	5.64e-05	0.000219	CcSEcCtD
Venlafaxine—Hypotension—Epirubicin—urinary bladder cancer	5.61e-05	0.000218	CcSEcCtD
Venlafaxine—Confusional state—Doxorubicin—urinary bladder cancer	5.6e-05	0.000217	CcSEcCtD
Venlafaxine—Decreased appetite—Methotrexate—urinary bladder cancer	5.57e-05	0.000216	CcSEcCtD
Venlafaxine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	5.55e-05	0.000216	CcSEcCtD
Venlafaxine—Oedema—Doxorubicin—urinary bladder cancer	5.55e-05	0.000216	CcSEcCtD
Venlafaxine—Fatigue—Methotrexate—urinary bladder cancer	5.53e-05	0.000215	CcSEcCtD
Venlafaxine—Infection—Doxorubicin—urinary bladder cancer	5.51e-05	0.000214	CcSEcCtD
Venlafaxine—Pain—Methotrexate—urinary bladder cancer	5.48e-05	0.000213	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.47e-05	0.000212	CcSEcCtD
Venlafaxine—Shock—Doxorubicin—urinary bladder cancer	5.46e-05	0.000212	CcSEcCtD
Venlafaxine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	5.44e-05	0.000211	CcSEcCtD
Venlafaxine—Insomnia—Epirubicin—urinary bladder cancer	5.43e-05	0.000211	CcSEcCtD
Venlafaxine—Tachycardia—Doxorubicin—urinary bladder cancer	5.42e-05	0.00021	CcSEcCtD
Venlafaxine—Paraesthesia—Epirubicin—urinary bladder cancer	5.39e-05	0.000209	CcSEcCtD
Venlafaxine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	5.37e-05	0.000208	CcSEcCtD
Venlafaxine—Dyspnoea—Epirubicin—urinary bladder cancer	5.35e-05	0.000208	CcSEcCtD
Venlafaxine—Somnolence—Epirubicin—urinary bladder cancer	5.33e-05	0.000207	CcSEcCtD
Venlafaxine—Anorexia—Doxorubicin—urinary bladder cancer	5.29e-05	0.000205	CcSEcCtD
Venlafaxine—Feeling abnormal—Methotrexate—urinary bladder cancer	5.28e-05	0.000205	CcSEcCtD
Venlafaxine—Dyspepsia—Epirubicin—urinary bladder cancer	5.28e-05	0.000205	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5.24e-05	0.000204	CcSEcCtD
Venlafaxine—Decreased appetite—Epirubicin—urinary bladder cancer	5.22e-05	0.000203	CcSEcCtD
Venlafaxine—Hypotension—Doxorubicin—urinary bladder cancer	5.19e-05	0.000201	CcSEcCtD
Venlafaxine—Fatigue—Epirubicin—urinary bladder cancer	5.17e-05	0.000201	CcSEcCtD
Venlafaxine—Pain—Epirubicin—urinary bladder cancer	5.13e-05	0.000199	CcSEcCtD
Venlafaxine—Constipation—Epirubicin—urinary bladder cancer	5.13e-05	0.000199	CcSEcCtD
Venlafaxine—Urticaria—Methotrexate—urinary bladder cancer	5.09e-05	0.000198	CcSEcCtD
Venlafaxine—Abdominal pain—Methotrexate—urinary bladder cancer	5.07e-05	0.000197	CcSEcCtD
Venlafaxine—Body temperature increased—Methotrexate—urinary bladder cancer	5.07e-05	0.000197	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	5.06e-05	0.000196	CcSEcCtD
Venlafaxine—Insomnia—Doxorubicin—urinary bladder cancer	5.02e-05	0.000195	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—SLC19A1—urinary bladder cancer	5.01e-05	0.000721	CbGpPWpGaD
Venlafaxine—Paraesthesia—Doxorubicin—urinary bladder cancer	4.98e-05	0.000194	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	4.98e-05	0.000717	CbGpPWpGaD
Venlafaxine—Dyspnoea—Doxorubicin—urinary bladder cancer	4.95e-05	0.000192	CcSEcCtD
Venlafaxine—Feeling abnormal—Epirubicin—urinary bladder cancer	4.94e-05	0.000192	CcSEcCtD
Venlafaxine—Somnolence—Doxorubicin—urinary bladder cancer	4.93e-05	0.000192	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL8—urinary bladder cancer	4.91e-05	0.000708	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	4.91e-05	0.00019	CcSEcCtD
Venlafaxine—Dyspepsia—Doxorubicin—urinary bladder cancer	4.89e-05	0.00019	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—PRSS3—urinary bladder cancer	4.88e-05	0.000703	CbGpPWpGaD
Venlafaxine—Decreased appetite—Doxorubicin—urinary bladder cancer	4.83e-05	0.000187	CcSEcCtD
Venlafaxine—Fatigue—Doxorubicin—urinary bladder cancer	4.79e-05	0.000186	CcSEcCtD
Venlafaxine—Urticaria—Epirubicin—urinary bladder cancer	4.77e-05	0.000185	CcSEcCtD
Venlafaxine—Pain—Doxorubicin—urinary bladder cancer	4.75e-05	0.000184	CcSEcCtD
Venlafaxine—Constipation—Doxorubicin—urinary bladder cancer	4.75e-05	0.000184	CcSEcCtD
Venlafaxine—Body temperature increased—Epirubicin—urinary bladder cancer	4.74e-05	0.000184	CcSEcCtD
Venlafaxine—Abdominal pain—Epirubicin—urinary bladder cancer	4.74e-05	0.000184	CcSEcCtD
Venlafaxine—Hypersensitivity—Methotrexate—urinary bladder cancer	4.72e-05	0.000183	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	4.72e-05	0.00068	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NAT1—urinary bladder cancer	4.72e-05	0.00068	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL2—urinary bladder cancer	4.69e-05	0.000676	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TERT—urinary bladder cancer	4.68e-05	0.000674	CbGpPWpGaD
Venlafaxine—Asthenia—Methotrexate—urinary bladder cancer	4.6e-05	0.000179	CcSEcCtD
Venlafaxine—Feeling abnormal—Doxorubicin—urinary bladder cancer	4.57e-05	0.000178	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	4.54e-05	0.000654	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	4.54e-05	0.000176	CcSEcCtD
Venlafaxine—Pruritus—Methotrexate—urinary bladder cancer	4.54e-05	0.000176	CcSEcCtD
Venlafaxine—Hypersensitivity—Epirubicin—urinary bladder cancer	4.42e-05	0.000172	CcSEcCtD
Venlafaxine—Urticaria—Doxorubicin—urinary bladder cancer	4.41e-05	0.000171	CcSEcCtD
Venlafaxine—Body temperature increased—Doxorubicin—urinary bladder cancer	4.39e-05	0.00017	CcSEcCtD
Venlafaxine—Abdominal pain—Doxorubicin—urinary bladder cancer	4.39e-05	0.00017	CcSEcCtD
Venlafaxine—Diarrhoea—Methotrexate—urinary bladder cancer	4.39e-05	0.00017	CcSEcCtD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	4.38e-05	0.000631	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	4.32e-05	0.000622	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—urinary bladder cancer	4.31e-05	0.000621	CbGpPWpGaD
Venlafaxine—Asthenia—Epirubicin—urinary bladder cancer	4.3e-05	0.000167	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—FGFR3—urinary bladder cancer	4.29e-05	0.000618	CbGpPWpGaD
Venlafaxine—Pruritus—Epirubicin—urinary bladder cancer	4.24e-05	0.000165	CcSEcCtD
Venlafaxine—Dizziness—Methotrexate—urinary bladder cancer	4.24e-05	0.000165	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—ESR1—urinary bladder cancer	4.17e-05	0.000601	CbGpPWpGaD
Venlafaxine—Diarrhoea—Epirubicin—urinary bladder cancer	4.1e-05	0.000159	CcSEcCtD
Venlafaxine—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.09e-05	0.000159	CcSEcCtD
Venlafaxine—Vomiting—Methotrexate—urinary bladder cancer	4.08e-05	0.000158	CcSEcCtD
Venlafaxine—Rash—Methotrexate—urinary bladder cancer	4.04e-05	0.000157	CcSEcCtD
Venlafaxine—Dermatitis—Methotrexate—urinary bladder cancer	4.04e-05	0.000157	CcSEcCtD
Venlafaxine—Headache—Methotrexate—urinary bladder cancer	4.02e-05	0.000156	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.01e-05	0.000578	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4e-05	0.000576	CbGpPWpGaD
Venlafaxine—Asthenia—Doxorubicin—urinary bladder cancer	3.98e-05	0.000155	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	3.98e-05	0.000573	CbGpPWpGaD
Venlafaxine—Dizziness—Epirubicin—urinary bladder cancer	3.97e-05	0.000154	CcSEcCtD
Venlafaxine—Pruritus—Doxorubicin—urinary bladder cancer	3.93e-05	0.000153	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	3.91e-05	0.000563	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TYMP—urinary bladder cancer	3.9e-05	0.000562	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	3.89e-05	0.00056	CbGpPWpGaD
Venlafaxine—Vomiting—Epirubicin—urinary bladder cancer	3.81e-05	0.000148	CcSEcCtD
Venlafaxine—Nausea—Methotrexate—urinary bladder cancer	3.81e-05	0.000148	CcSEcCtD
Venlafaxine—Diarrhoea—Doxorubicin—urinary bladder cancer	3.8e-05	0.000147	CcSEcCtD
Venlafaxine—Rash—Epirubicin—urinary bladder cancer	3.78e-05	0.000147	CcSEcCtD
Venlafaxine—Dermatitis—Epirubicin—urinary bladder cancer	3.78e-05	0.000147	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	3.76e-05	0.000542	CbGpPWpGaD
Venlafaxine—Headache—Epirubicin—urinary bladder cancer	3.76e-05	0.000146	CcSEcCtD
Venlafaxine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.69e-05	0.000532	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.67e-05	0.000529	CbGpPWpGaD
Venlafaxine—Dizziness—Doxorubicin—urinary bladder cancer	3.67e-05	0.000143	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	3.67e-05	0.000529	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CREBBP—urinary bladder cancer	3.65e-05	0.000526	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.64e-05	0.000525	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IGF1—urinary bladder cancer	3.61e-05	0.00052	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—EGFR—urinary bladder cancer	3.59e-05	0.000517	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	3.58e-05	0.000515	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	3.57e-05	0.000514	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	3.57e-05	0.000514	CbGpPWpGaD
Venlafaxine—Nausea—Epirubicin—urinary bladder cancer	3.56e-05	0.000138	CcSEcCtD
Venlafaxine—Vomiting—Doxorubicin—urinary bladder cancer	3.53e-05	0.000137	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—NAT2—urinary bladder cancer	3.53e-05	0.000508	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.51e-05	0.000505	CbGpPWpGaD
Venlafaxine—Rash—Doxorubicin—urinary bladder cancer	3.5e-05	0.000136	CcSEcCtD
Venlafaxine—Dermatitis—Doxorubicin—urinary bladder cancer	3.5e-05	0.000136	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.49e-05	0.000502	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.48e-05	0.000501	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.48e-05	0.000501	CbGpPWpGaD
Venlafaxine—Headache—Doxorubicin—urinary bladder cancer	3.48e-05	0.000135	CcSEcCtD
Venlafaxine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	3.46e-05	0.000498	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.44e-05	0.000496	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	3.43e-05	0.000494	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	3.39e-05	0.000489	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—KRAS—urinary bladder cancer	3.39e-05	0.000489	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.35e-05	0.000482	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RHOA—urinary bladder cancer	3.31e-05	0.000476	CbGpPWpGaD
Venlafaxine—Nausea—Doxorubicin—urinary bladder cancer	3.3e-05	0.000128	CcSEcCtD
Venlafaxine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	3.28e-05	0.000473	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	3.28e-05	0.000473	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	3.26e-05	0.00047	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	3.25e-05	0.000468	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NAT1—urinary bladder cancer	3.25e-05	0.000468	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.2e-05	0.000461	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.18e-05	0.000459	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.15e-05	0.000454	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.14e-05	0.000453	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ERBB2—urinary bladder cancer	3.06e-05	0.000441	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—RRM2—urinary bladder cancer	3.04e-05	0.000439	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	3e-05	0.000432	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	2.97e-05	0.000428	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.96e-05	0.000426	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	2.94e-05	0.000423	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.92e-05	0.000421	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCL8—urinary bladder cancer	2.9e-05	0.000418	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—HRAS—urinary bladder cancer	2.88e-05	0.000415	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.87e-05	0.000413	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TYMP—urinary bladder cancer	2.86e-05	0.000412	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.86e-05	0.000411	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—HPGDS—urinary bladder cancer	2.82e-05	0.000406	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ENO2—urinary bladder cancer	2.82e-05	0.000406	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.79e-05	0.000401	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	2.77e-05	0.0004	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL2—urinary bladder cancer	2.77e-05	0.0004	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTT1—urinary bladder cancer	2.74e-05	0.000394	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.71e-05	0.00039	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCND1—urinary bladder cancer	2.7e-05	0.000389	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	2.7e-05	0.000389	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	2.7e-05	0.000389	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	2.68e-05	0.000386	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.64e-05	0.00038	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MMP9—urinary bladder cancer	2.62e-05	0.000378	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CDKN1A—urinary bladder cancer	2.62e-05	0.000377	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTEN—urinary bladder cancer	2.61e-05	0.000376	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NAT2—urinary bladder cancer	2.59e-05	0.000373	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.58e-05	0.000372	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.56e-05	0.000369	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	2.55e-05	0.000367	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	2.53e-05	0.000364	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.5e-05	0.00036	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.49e-05	0.000359	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EP300—urinary bladder cancer	2.49e-05	0.000358	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	2.49e-05	0.000358	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	2.46e-05	0.000355	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SRC—urinary bladder cancer	2.42e-05	0.000349	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—HRAS—urinary bladder cancer	2.41e-05	0.000348	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.37e-05	0.000342	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.31e-05	0.000333	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NQO1—urinary bladder cancer	2.27e-05	0.000327	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.26e-05	0.000326	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—RRM2—urinary bladder cancer	2.23e-05	0.000322	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MYC—urinary bladder cancer	2.17e-05	0.000312	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.17e-05	0.000312	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	2.16e-05	0.000311	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.14e-05	0.000309	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.14e-05	0.000309	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGFR—urinary bladder cancer	2.12e-05	0.000306	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.11e-05	0.000304	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.08e-05	0.000299	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.07e-05	0.000298	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.07e-05	0.000298	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.07e-05	0.000298	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.02e-05	0.000292	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2e-05	0.000289	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—KRAS—urinary bladder cancer	2e-05	0.000289	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.99e-05	0.000286	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.98e-05	0.000285	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.97e-05	0.000284	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.96e-05	0.000283	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	1.95e-05	0.000281	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.93e-05	0.000278	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.91e-05	0.000275	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.91e-05	0.000275	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTP1—urinary bladder cancer	1.9e-05	0.000273	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.89e-05	0.000273	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.8e-05	0.000259	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.78e-05	0.000257	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—urinary bladder cancer	1.78e-05	0.000257	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.77e-05	0.000254	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.76e-05	0.000254	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1.74e-05	0.000251	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1.74e-05	0.000251	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HRAS—urinary bladder cancer	1.7e-05	0.000245	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.7e-05	0.000245	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.69e-05	0.000243	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GPX1—urinary bladder cancer	1.67e-05	0.00024	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.67e-05	0.00024	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.67e-05	0.00024	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.65e-05	0.000237	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ERCC2—urinary bladder cancer	1.64e-05	0.000236	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.63e-05	0.000234	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.56e-05	0.000225	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.56e-05	0.000225	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.55e-05	0.000224	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.55e-05	0.000223	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—MTHFR—urinary bladder cancer	1.54e-05	0.000222	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.54e-05	0.000222	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.52e-05	0.00022	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.52e-05	0.00022	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.52e-05	0.000218	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.49e-05	0.000215	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.48e-05	0.000213	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.44e-05	0.000207	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.44e-05	0.000207	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.42e-05	0.000205	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.42e-05	0.000205	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.42e-05	0.000204	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.39e-05	0.000201	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.39e-05	0.0002	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.38e-05	0.000199	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.38e-05	0.000199	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.36e-05	0.000196	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.3e-05	0.000187	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.29e-05	0.000186	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.28e-05	0.000184	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.28e-05	0.000184	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.26e-05	0.000181	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PPARG—urinary bladder cancer	1.25e-05	0.00018	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.23e-05	0.000177	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.22e-05	0.000176	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.22e-05	0.000176	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.2e-05	0.000173	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CREBBP—urinary bladder cancer	1.2e-05	0.000173	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.17e-05	0.000169	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.16e-05	0.000167	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.15e-05	0.000165	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.13e-05	0.000163	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.11e-05	0.00016	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.07e-05	0.000153	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.05e-05	0.000151	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.03e-05	0.000148	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.02e-05	0.000146	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.01e-05	0.000146	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS2—urinary bladder cancer	9.82e-06	0.000141	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	9.76e-06	0.000141	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.71e-06	0.00014	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	9.66e-06	0.000139	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	9.65e-06	0.000139	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	9.65e-06	0.000139	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	9.58e-06	0.000138	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TYMS—urinary bladder cancer	9.53e-06	0.000137	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	9.42e-06	0.000136	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	9.42e-06	0.000136	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	9.39e-06	0.000135	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	9.39e-06	0.000135	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.26e-06	0.000133	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	9.24e-06	0.000133	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	9.15e-06	0.000132	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.11e-06	0.000131	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	9.07e-06	0.000131	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.02e-06	0.00013	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	8.98e-06	0.000129	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	8.9e-06	0.000128	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	8.88e-06	0.000128	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	8.88e-06	0.000128	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	8.86e-06	0.000128	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	8.8e-06	0.000127	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	8.8e-06	0.000127	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	8.79e-06	0.000127	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTEN—urinary bladder cancer	8.57e-06	0.000123	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	8.53e-06	0.000123	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	8.5e-06	0.000122	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	8.43e-06	0.000121	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	8.35e-06	0.00012	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.32e-06	0.00012	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	8.27e-06	0.000119	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—EP300—urinary bladder cancer	8.17e-06	0.000118	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	7.84e-06	0.000113	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	7.78e-06	0.000112	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	7.57e-06	0.000109	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	7.2e-06	0.000104	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	6.92e-06	9.96e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PPARG—urinary bladder cancer	6.75e-06	9.72e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	6.64e-06	9.57e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.48e-06	9.34e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	6.36e-06	9.16e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.32e-06	9.1e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	6.31e-06	9.08e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	6.28e-06	9.05e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	6.11e-06	8.8e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	6.06e-06	8.73e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—EP300—urinary bladder cancer	5.99e-06	8.63e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.87e-06	8.46e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.8e-06	8.36e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.8e-06	8.36e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.56e-06	8.01e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.46e-06	7.86e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	5.44e-06	7.84e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.31e-06	7.65e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.13e-06	7.39e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	5e-06	7.21e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	4.96e-06	7.15e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	4.74e-06	6.84e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.63e-06	6.67e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—EP300—urinary bladder cancer	4.52e-06	6.52e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—EP300—urinary bladder cancer	4.42e-06	6.36e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	4.36e-06	6.29e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	4.33e-06	6.23e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—EP300—urinary bladder cancer	4.16e-06	6e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.16e-06	5.99e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—EP300—urinary bladder cancer	4.13e-06	5.94e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4e-06	5.76e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.27e-06	4.71e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.85e-06	4.11e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.72e-06	3.92e-05	CbGpPWpGaD
